MX2023000999A - Implante intraocular con alta carga de una prostamida. - Google Patents

Implante intraocular con alta carga de una prostamida.

Info

Publication number
MX2023000999A
MX2023000999A MX2023000999A MX2023000999A MX2023000999A MX 2023000999 A MX2023000999 A MX 2023000999A MX 2023000999 A MX2023000999 A MX 2023000999A MX 2023000999 A MX2023000999 A MX 2023000999A MX 2023000999 A MX2023000999 A MX 2023000999A
Authority
MX
Mexico
Prior art keywords
prostamide
high loading
intraocular implant
intraocular
glaucoma
Prior art date
Application number
MX2023000999A
Other languages
English (en)
Inventor
Alazar N Ghebremeskel
Jinping Wan
James J Cunningham
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of MX2023000999A publication Critical patent/MX2023000999A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)

Abstract

Se describen implantes intraoculares biodegradables con una alta carga de un compuesto de prostamida para la reducción inmediata y sostenida de la presión intraocular y el tratamiento del glaucoma en el ojo de un paciente.
MX2023000999A 2020-07-21 2021-07-20 Implante intraocular con alta carga de una prostamida. MX2023000999A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063054620P 2020-07-21 2020-07-21
PCT/US2021/042361 WO2022020347A1 (en) 2020-07-21 2021-07-20 Intraocular implant with high loading of a prostamide

Publications (1)

Publication Number Publication Date
MX2023000999A true MX2023000999A (es) 2023-03-01

Family

ID=77338832

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023000999A MX2023000999A (es) 2020-07-21 2021-07-20 Implante intraocular con alta carga de una prostamida.

Country Status (12)

Country Link
US (1) US20220023095A1 (es)
EP (1) EP4185299A1 (es)
JP (1) JP2023535399A (es)
KR (1) KR20230042049A (es)
CN (1) CN116133663A (es)
AU (1) AU2021313151A1 (es)
BR (1) BR112023001073A2 (es)
CA (1) CA3184991A1 (es)
IL (1) IL299577A (es)
MX (1) MX2023000999A (es)
TW (1) TW202216159A (es)
WO (1) WO2022020347A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3062775T3 (pl) * 2013-10-31 2018-05-30 Allergan, Inc. Implanty wewnątrzgałkowe zawierające prostamid i sposoby ich stosowania

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834498A (en) 1992-09-21 1998-11-10 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6602900B2 (en) 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6124344A (en) 1993-12-28 2000-09-26 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5741810A (en) 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
US6899717B2 (en) 2002-09-18 2005-05-31 Allergan, Inc. Methods and apparatus for delivery of ocular implants
US20230026451A1 (en) * 2004-04-30 2023-01-26 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US20100278897A1 (en) 2009-05-01 2010-11-04 Allergan, Inc. Intraocular bioactive agent delivery system with molecular partitioning system
TWI631961B (zh) * 2013-03-15 2018-08-11 美商歐樂根公司 含有前列醯胺之眼內植入物
SG10201701938PA (en) * 2013-04-12 2017-04-27 Allergan Inc Sustained release of bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
PL3062775T3 (pl) * 2013-10-31 2018-05-30 Allergan, Inc. Implanty wewnątrzgałkowe zawierające prostamid i sposoby ich stosowania
US10765629B2 (en) * 2017-07-25 2020-09-08 Allergan, Inc. Solid complex, preparations and uses thereof
US20190192341A1 (en) * 2017-11-09 2019-06-27 Allergan, Inc. Sustained-Release Implants for Lowering Intraocular Pressure with Extended Duration of Effect

Also Published As

Publication number Publication date
BR112023001073A2 (pt) 2023-03-07
TW202216159A (zh) 2022-05-01
KR20230042049A (ko) 2023-03-27
US20220023095A1 (en) 2022-01-27
CA3184991A1 (en) 2022-01-27
EP4185299A1 (en) 2023-05-31
WO2022020347A1 (en) 2022-01-27
AU2021313151A1 (en) 2023-03-16
CN116133663A (zh) 2023-05-16
JP2023535399A (ja) 2023-08-17
IL299577A (en) 2023-03-01

Similar Documents

Publication Publication Date Title
CY1120147T1 (el) Βιοαποικοδομησιμο οφθαλμικο εμφυτευμα
EP4316594A3 (en) Intraocular pressure reduction with intracameral bimatoprost implants
TW200621263A (en) Ocular implant made by a double extrusion process
MX2011007804A (es) Suministro de liberación sostenida de uno o más agentes.
MX2020002381A (es) Implantes intraoculares que contienen prostamida y metodos para su uso.
ATE304823T1 (de) Augenhornhautimplantat
WO2009137085A3 (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
Schmitzer et al. The anophthalmic socket–reconstruction options
MX2023000999A (es) Implante intraocular con alta carga de una prostamida.
CN110678147B (zh) 用于晶状体囊的修复和张紧的设备
WO2007047242A3 (en) Ophthalmic surgical irrigating solutions containing hyaluronidase
WO2022251710A3 (en) Intraocular devices, systems, and methods
US20140074234A1 (en) Scleral Epimacular Implant
MD3502G2 (ro) Metodă de tratament al cataractei traumatice
Chen et al. High density porous polyethylene material (Medpor) as an unwrapped orbital implant
MX2022009435A (es) Composiciones y metodos para el tratamiento de enfermedades oculares.
WO2017039488A1 (ru) Способ проведения офтальмохирургических операций с использованием аутотрансплантата
TWD227104S (zh) 流體交換裝置
US20190053889A1 (en) Artificial iris having pouch
Ozcan et al. Scleral fixation–Where are we
LT2017519A (lt) Panirusio intraokulinio lęšio fiksavimo akyje prietaisas
Yousef Enucleation surgery—orbital implants and surgical techniques
Baxter Internal bra: a unifying solution for reconstructive and aesthetic breast surgery issues
Maurya et al. Traumatic subconjunctival dislocation of fractured posterior chamber intraocular lens by cow horn injury
Budo Iris Repair after Long-Term Complications of Angle-Supported Phakic Intraocular Lenses